Archer Investment Corporation’s AbbVie ABBV Stock Holding History

Archer Investment Corporation’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.63M	Buy	6,483 +9	+0.1%	+$1.94K	0.32%	60
2026 Q1	$1.41M	Sell	6,474 -158	-2%	-$35K	0.3%	68
2025 Q4	$1.52M	Sell	6,632 -1,472	-18%	-$335K	0.34%	62
2025 Q3	$1.88M	Sell	8,104 -678	-8%	-$138K	0.42%	46
2025 Q2	$1.63M	Sell	8,782 -4	-0%	-$743	0.39%	53
2025 Q1	$1.84M	Buy	8,786 +733	+9%	+$142K	0.48%	47
2024 Q4	$1.43M	Buy	8,053 +140	+2%	+$25.7K	0.38%	54
2024 Q3	$1.56M	Sell	7,913 -21	-0.3%	-$3.92K	0.42%	53
2024 Q2	$1.36M	Buy	7,934 +411	+5%	+$68.1K	0.4%	57
2024 Q1	$1.37M	Sell	7,523 -139	-2%	-$24K	0.41%	56
2023 Q4	$1.19M	Buy	7,662 +13	+0.2%	+$1.9K	0.38%	58
2023 Q3	$1.14M	Buy	7,649 +11	+0.1%	+$1.61K	0.4%	61
2023 Q2	$1.03M	Sell	7,638 -1,710	-18%	-$251K	0.37%	65
2023 Q1	$1.41M	Buy	9,348 +406	+5%	+$62.1K	0.52%	43
2022 Q4	$1.45M	Buy	8,942 +29	+0.3%	+$4.45K	0.56%	37
2022 Q3	$1.2M	Buy	8,913 +11	+0.1%	+$1.58K	0.5%	45
2022 Q2	$1.36M	Buy	8,902 +30	+0.3%	+$4.58K	0.55%	37
2022 Q1	$1.45M	Sell	8,872 -89	-1%	-$12.9K	0.51%	42
2021 Q4	$1.21M	Buy	8,961 +91	+1%	+$10.7K	0.41%	62
2021 Q3	$957K	Buy	8,870 +51	+0.6%	+$5.83K	0.36%	68
2021 Q2	$993K	Buy	8,819 +5	+0.1%	+$563	0.39%	58
2021 Q1	$954K	Hold	8,814	–	–	0.39%	58
2020 Q4	$944K	Sell	8,814 -258	-3%	-$24.8K	0.45%	51
2020 Q3	$795K	Sell	9,072 -143	-2%	-$13.5K	0.41%	55
2020 Q2	$905K	Buy	9,215 +108	+1%	+$9.51K	0.51%	43
2020 Q1	$694K	Buy	9,107 +1,893	+26%	+$161K	0.47%	46
2019 Q4	$638K	Buy	7,214 +1,270	+21%	+$105K	0.34%	66
2019 Q3	$450K	Sell	5,944 -617,262	-99%	-$42.3M	0.27%	92
2019 Q2	$450K	Buy	623,206 +613,162	+6,105%	+$48.2M	0.29%	81
2019 Q1	$820K	Buy	10,044 +560	+6%	+$45.8K	0.55%	40
2018 Q4	$874K	Buy	+9,484	New	+$834K	0.77%	33

Other funds holding ABBV

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Archer Investment Corporation's ABBV Position: Q2 2026 in Review

Archer Investment Corporation increased its AbbVie (ABBV) stake by 0.14% in Q2 2026, buying an estimated $1.94K and bringing the position to 6,483 shares worth $1.63M. The position accounts for 0.32% of the portfolio, ranked #60.

Archer Investment Corporation first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.88M in Q3 2025. 2,345 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Archer Investment Corporation held 6,483 shares of AbbVie worth $1.63M as of Q2 2026.
Archer Investment Corporation bought 9 AbbVie shares in Q2 2026, an estimated $1.94K.
AbbVie made up 0.32% of Archer Investment Corporation's portfolio in Q2 2026, its #60 holding.
Archer Investment Corporation first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
Archer Investment Corporation's AbbVie position peaked at $1.88M in Q3 2025.
2,345 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Archer Investment Corporation's 13F filing for Q2 2026, filed 3 Aug 2026.